Etonogestrel

Results: 18



#Item
11HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. ®

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-11-07 17:30:30
12Patient Information NuvaRing® (NEW-vah-ring) (etonogestrel/ethinyl estradiol vaginal ring) What is the most important information I should know about NuvaRing?

Patient Information NuvaRing® (NEW-vah-ring) (etonogestrel/ethinyl estradiol vaginal ring) What is the most important information I should know about NuvaRing?

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2014-11-07 17:30:31
13Contraceptive Implant Approved by FDA September 2006 Women in the US will soon have another contraceptive method available to them. The Food and Drug Administration has approved Implanon, a contraceptive implant. It’s

Contraceptive Implant Approved by FDA September 2006 Women in the US will soon have another contraceptive method available to them. The Food and Drug Administration has approved Implanon, a contraceptive implant. It’s

Add to Reading List

Source URL: www.idahoperinatal.org

Language: English - Date: 2010-08-10 15:26:15
14MIRCETTE® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets[removed]

MIRCETTE® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets[removed]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-07-19 14:15:07
15Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Marvelon

Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Marvelon

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-03-07 11:19:28
16Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Cerazette (Desogestrel)

Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Cerazette (Desogestrel)

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2012-03-07 11:19:27
17HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing information for NEXPLANON. •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing information for NEXPLANON. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-06-01 14:34:51
18HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl est

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NuvaRing safely and effectively. See full prescribing information for NuvaRing. NuvaRing® (etonogestrel/ethinyl est

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-23 15:51:16